IHRD-ARL undertakes formulation development of Pharmaceuticals ranging from immediate release formulations for oral administration to alternative dosage designs and controlled release formulations, aided by state-of-the-art technology and equipments. Formulation designs include Ethical Products.
Pharmaceutical Formulation Development
- Solid oral
- Topical dosage form
- Parenterals
Activities involved
- Literature Information & Primary Patent Status Evaluation
- Preformulation study
- Prototype Formulation Development
- Packaging Development
- Scale-up of selected Prototype Formulation
- Process Optimization
- Process Validation
- Manufacture of Exhibit/Bio-batch
- Bio-Equivalence Study
- Product Development Report
- Documentation in CTD Format
- Technology Transfer
- Stability Study